Global Point-of-Care Diagnostics Market Set to Skyrocket to USD 74.8 Billion by 2033

The healthcare landscape is rapidly evolving, driven by groundbreaking technological advancements. At the forefront of this transformative wave is the global point-of-care diagnostics market. According to the latest research findings from Future Market Insights, this market segment is poised for unprecedented growth, projected to expand at a Compound Annual Growth Rate (CAGR) of 6.8% over the forecasted period.

As of 2022, the point-of-care diagnostics market was valued at USD 36.6 billion. By the end of 2023, it is anticipated to witness a substantial year-over-year increase of 5.8%, reaching USD 38.7 billion. This remarkable growth trajectory underscores the indispensable role played by point-of-care diagnostics in reshaping healthcare delivery on a global scale.

Prepare To Thrive And Conquer New Horizons With Our Sample Report – Get It Now

By 2033, the market is expected to soar to an astounding USD 74.8 billion, showcasing the immense potential and demand for innovative diagnostic solutions that offer timely and accurate results. This projected expansion signifies not only a significant leap in market value but also reflects the increasing adoption and acceptance of point-of-care diagnostics across diverse healthcare settings.

Point-of-care diagnostics empower healthcare professionals with the ability to rapidly assess and diagnose patients, leading to enhanced clinical decision-making, streamlined workflows, and improved patient outcomes. With the convenience of near-patient testing, these diagnostic solutions are revolutionizing healthcare delivery by bringing diagnostics closer to the point of patient care.

The exponential growth of the global point-of-care diagnostics market underscores its pivotal role in driving innovation and efficiency within the healthcare industry. As we continue to witness technological advancements and evolving healthcare needs, the future holds immense promise for further advancements in point-of-care diagnostics, ultimately benefiting patients and healthcare providers worldwide.

The Global Impact Point-of-Care Diagnostics Market:

The impact of Point-of-Care diagnostics extends far beyond individual healthcare facilities. As these technologies gain traction, they have the potential to revolutionize healthcare systems worldwide. In resource-constrained regions, POC diagnostics can play a pivotal role in early disease detection and monitoring, leading to better outcomes and reduced healthcare costs. Moreover, in developed countries, the integration of POC devices into home care settings empowers patients to actively manage their health conditions, resulting in improved overall well-being and reduced hospital readmissions.

Key Takeaways in the Point-of-Care Diagnostics Market:

As the healthcare industry evolves rapidly, point-of-care diagnostics have emerged as a pivotal player in revolutionizing patient care. These portable and rapid testing solutions have several key takeaways that warrant attention from stakeholders and investors alike.

  • Soaring Demand for Immediate Results: The Point-of-Care Diagnostics Market is witnessing a surge in demand due to the growing need for immediate and accurate test results. With healthcare professionals and patients alike seeking faster diagnoses, these portable devices are proving to be game-changers, reducing the turnaround time for critical medical decisions.
  • Technological Advancements Propel Market Growth: The market’s progress is significantly driven by rapid technological advancements. Innovations in microfluidics, biosensors, and smartphone integration are transforming the landscape, allowing for more efficient and user-friendly devices. The integration of Artificial Intelligence (AI) and Internet of Things (IoT) technologies further enhances the capabilities of these diagnostic tools, promising a bright future for the industry.
  • Expanding Application Scope: Point-of-care diagnostics are no longer limited to traditional healthcare settings. Their application scope has expanded into remote areas, ambulances, home care, and disaster-stricken regions. The market’s versatility has enabled access to medical testing in underserved areas, ensuring equitable healthcare distribution.
  • Rising Prevalence of Infectious Diseases: The global prevalence of infectious diseases, such as COVID-19, has catalyzed the demand for rapid testing solutions. Point-of-care diagnostics are playing a crucial role in controlling outbreaks by enabling quick identification and containment of infectious agents.
  • Cost-Effectiveness and Healthcare System Optimization: The implementation of point-of-care diagnostics contributes to cost-effectiveness and optimization of healthcare systems. By reducing the need for laboratory infrastructure, transportation, and centralized testing, these devices offer potential cost savings and improved resource allocation.

Seize the Advantage Instantly Access the Full Report

Competitive Landscape:

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson & Company
  • Cepheid (Danaher)
  • Siemens Healthineers
  • Abbott
  • Diasorin S.p.a.
  • Thermo Fisher Scientific Inc.
  • Qiagen
  • BIOMÉRIEUX
  • Hologic Inc.
  • Bio Rad Laboratories
  • Quidel Corporation
  • EKF Diagnostics
  • SEKISUI Diagnostics
  • DiaSys-Diagnostic Systems GmbH
  • InBios International, Inc.
  • Jiangsu Mole Bioscience Co., Ltd.
  • ACON Laboratories, Inc.
  • Visby Medical, Inc.
  • UNIMA, INC.

Key Segments Covered in Global Point-of-Care Diagnostics Industry Research:

By Product:

  • Dipstick
  • Strips & Cards
  • Cassettes
  • Handheld POC Monitoring Devices

By Sample:

  • Saliva
  • Nasal Swabs
  • Urine
  • Blood
  • Plasma
  • Sweat
  • Other Fluids

By Test Type:

  • COVID-19 Testing
  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation Testing
  • Pregnancy & Fertility Testing
  • Allergy Tests
  • Cholesterol & Lipids Tests
  • Drug of Abuse (DOA) Testing
  • Food Sensitivity Tests
  • Metabolism Tests
  • Vitamin D Tests
  • Vitamins B Test
  • Urinary Tract Infection (UTI) Tests
  • Sexual Health Tests
  • Water Testing Kits
  • Alcohol Tests
  • Others
  • Infectious Disease
    • HIV POC Testing
    • Clostridium Difficile POC Testing
    • HBV POC Testing
    • Pneumonia or Streptococcus Associated Infections Testing
    • Respiratory Syncytial Virus (RSV) POC Testing
    • HPV POC
    • Influenza/Flu POC Testing
    • HCV POC Testing
    • MRSA POC Testing
    • TB and Drug-resistant TB POC Testing & HSV POC Testing

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Non-Government Organization
  • Government & Federal Agencies
  • Long Term Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global IV Disposables Market Set for Remarkable Growth 11.8% CAGR, Reaching USD 51.6 Billion by 2033

The global IV disposables market is on the cusp of significant expansion, with Future Market Insights projecting a robust compound annual growth rate (CAGR) of 11.8% from 2023 to 2033. The market, currently valued at USD 17.0 billion in 2023, is expected to reach an impressive USD 51.6 billion by 2033.

This forecasted growth follows a strong performance in recent years, with the market recording a valuation of USD 15.5 billion in 2022. This marks a notable year-over-year growth of 9.6% leading into 2023, highlighting the increasing demand for IV disposables across diverse healthcare settings.

Request For A Sample IV Disposables Market…

The escalating demand is largely attributed to the widespread utilization of infusion pumps and related accessories in medical facilities as well as home care settings. IV disposables play a crucial role in delivering vital medications, fluids, and nutrients to patients, driving their adoption across the healthcare landscape.

“The market’s steady expansion reflects the increasing reliance on IV disposables for efficient and safe delivery of treatments in healthcare facilities worldwide,” stated a Future Market Insights. “With advancements in medical technology and a growing emphasis on patient-centric care, the demand for IV disposables is expected to continue its upward trajectory in the coming years.”

Key market players are anticipated to leverage this growth opportunity by focusing on product innovation, strategic collaborations, and expanding their geographical presence. By catering to evolving healthcare needs and ensuring product quality and reliability can position themselves to capitalize on the burgeoning demand for IV disposables.

To Put It Concisely, The Takeaway Is IV Disposables Market:

  • By Product, Infusion pumps are the leading segment as and held about 48.1% market share in 2022, due to efficiency, accuracy, and versatility in delivering fluids and medications in various healthcare settings.
  • By End User, the hospitals dominated the global IV disposables market withholding the total market share of about 54.6% by the end of 2022, as they offer specialized treatment options that require advanced IV therapies.
  • By Region, North America is leading in the global IV disposables market and is expected to continue to do so with a projected CAGR rate of 10.6% during the forecasted years, due to increasing prevalence of chronic diseases in the region.

Potential Elements That Might Limit the Expansion of the IV Disposables Market:

  • The IV disposables market is subject to stringent regulations to ensure patient safety and product quality. Changes in regulatory requirements or delays in obtaining approvals for new products can hinder market growth.
  • Healthcare providers, especially in cost-sensitive environments, might exert pressure to reduce the cost of IV disposables. This can lead to manufacturers facing challenges in maintaining profitability while keeping prices competitive.
  • The IV disposables market can become saturated with multiple manufacturers offering similar products. Intense competition can lead to price wars and reduced profit margins, making it challenging for companies to expand and invest in research and development.
  • Rapid advancements in medical technology could lead to the development of alternative treatment methods that reduce the reliance on traditional IV therapies, impacting the demand for IV disposables.

Gain Essential Insights Get the Complete Report

Key Companies Profiled:

  • B. Braun Melsungen AG
  • Baxter
  • 3M
  • Terumo Corporation
  • Nipro Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • Smiths Medical/ICU Medical
  • Moog Inc
  • AngioDynamics.
  • Fresenius SE & Co. KgaA
  • arcomed ag

Key Segments Covered in IV Disposables Market Industry Research:

By Product:

  • Intravenous Administration Set
  • IV Fluid Solution Bags
  • IV Cannula
  • Infusion Sets
  • Infusion Pumps
  • Catheter Needles
  • Securement Devices
  • Others (Stopcocks, connectors, Extention Tubes)

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Dermatology Excimer Lasers Market Poised for Significant Growth USD 258.4 Million by 2033, Reports Future Market Insights

Future Market Insights (FMI), a renowned provider of market intelligence and consulting services, has unveiled its latest industry analysis, highlighting a substantial growth trajectory in the global dermatology excimer lasers market. According to the report, the market is projected to experience a remarkable Compound Annual Growth Rate (CAGR) of 11.4%, driving its value from USD 87.7 million in 2023 to an impressive USD 258.4 million by 2033.

The dermatological excimer lasers market has shown consistent growth, reaching a valuation of USD 79.4 million by the end of 2022. The report forecasts a robust year-over-year expansion of 10.4% in 2023, indicating a strong and sustained upward trend.

Get your Sample Report Dermatology Excimer Lasers Market

A notable factor driving this growth is the increasing preference for ablative lasers in dermatological treatments. Unlike conventional excimer lasers, which may necessitate prolonged recovery periods and pose risks of thermal damage, ablative lasers offer a compelling combination of efficiency and safety. By efficiently eliminating the outer layers of aged and sun-damaged skin with their potent laser light, ablative lasers have emerged as the preferred choice among healthcare professionals and patients alike.

The forecasted expansion presents lucrative opportunities for market players to capitalize on the growing demand for advanced dermatological solutions. By investing in research and development initiatives and forging strategic collaborations, stakeholders can position themselves to harness the full potential of this burgeoning market.

Key Takeaways:

Trolley-mounted excimer lasers are the leading segment product among lasers, and held about 47.7% market share in 2022, due to their ability to provide physicians with a compact and versatile tool for the treatment of various skin conditions.

  • Psoriasis is a leading segment as an application, and held about 7% market share in 2022, due to escalating demand for more efficacious treatments has propelled industry players to adopt excimer lasers as preferred treatment methodologies for psoriasis.
  • By end user, the dermatology & cosmetic clinics dominated the global dermatology excimer lasers market holding a total market share of about 5% by the end of 2022, owing to the increasing demand for non-invasive and effective medical treatments used in these clinics becoming more common.
  • By region, North America is leading in the global dermatology excimer lasers market. The presence of numerous renowned laser manufacturers, research institutions, and medical device companies in North America has contributed to significant advancements and the development of cutting-edge laser technologies in the field of dermatology.

“Increasing adoption of aesthetic cosmetic procedures and growing awareness and diagnosis of skin diseases to create a lucrative potential for the market to grow,” says an analyst of Future Market Insights.

Market Competition:

Key participants are actively engaged in strategies such as acquisitions, mergers, collaborations, and partnerships to expand their companies. Key players in the market understand the importance of staying at the forefront of technological advancements. They invest in research and development to create innovative products that offer improved efficacy, precision, and patient outcomes. These advancements can range from refined laser systems and optimized treatment protocols to enhanced user interfaces and integrated software solutions.

  • Phoenix Rising Companies, a distributor of high-tech medical products, announced a definite MOU to buy Emvera Technologies, LLC in February 2022.
  • In July 2021, Quanta System and Clarion Medical Technologies Inc. teamed together to market and sell their cutting-edge portfolio of thulium and holmium laser systems, laser fibres, and accessories in Canada.

Maximize Your Strategy Get Immediate Access to the Full Report

Key Players:

  • Alma Laser
  • Ra Medical Systems
  • STRATA Skin Sciences
  • GSD – Global Skin Dermatologist (Shenzhen GSD Tech Co., Ltd)
  • Kernel Medical Equipment Co., LTD
  • KRUPA MEDI SCAN

Key Segments Covered in Dermatology Excimer Lasers Industry Research:

By Product:

  • Table Top Excimer Lasers
  • Handheld Excimer Lasers
  • Trolley Mounted Excimer Lasers

By Application:

  • Psoriasis
  • Vitiligo
  • Eczema/ Atopic Dermatitis
  • Allergic Rhinitis
  • Alopecia Areata
  • Others

By End User:

  • Hospitals
  • Dermatology & Cosmetic Clinics
  • Plastic Surgery Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Multi-Therapy Infusion Pumps Market Poised for Significant Growth, Projected to Reach USD 699.4 Billion by 2033

According to a recent study conducted by Future Market Insights (FMI), the global multi-therapy infusion pumps market is poised for remarkable growth, with projections indicating a staggering market valuation of USD 699.4 billion by the year 2033. Currently valued at USD 370.4 million in 2023, this market is expected to witness a robust compound annual growth rate (CAGR) of 6.6% over the coming decade.

The driving force behind this exponential growth lies in several pivotal factors. One of the primary catalysts is the escalating prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders worldwide. These conditions often necessitate long-term, multi-drug treatments, propelling the demand for advanced therapeutic solutions like multi-therapy infusion pumps.

Accelerate Your Success: Unlock the Secrets of the Multi-Therapy Infusion Pumps Market the Sample Report

Moreover, technological innovations in infusion pump design have revolutionized the healthcare landscape by enabling the simultaneous administration of multiple therapies. This breakthrough capability not only enhances patient convenience and comfort but also streamlines treatment procedures for healthcare providers.

As the market continues to expand, stakeholders across the healthcare spectrum, including manufacturers, clinicians, and policymakers, are urged to collaborate in harnessing these advancements to optimize patient outcomes and healthcare delivery.

Key Takeaways:

  • Global sales of multi-therapy infusion pumps are likely to soar at 6% CAGR through 2033.
  • Based on modality, table-top segment is forecast to exhibit a CAGR of 2% from 2023 to 2033.
  • By application, parenteral nutrition segment is expected to progress at 4% CAGR through 2033.
  • By end user, hospitals segment is anticipated to thrive at 2% CAGR during the forecast period.
  • The United States multi-therapy infusion pumps industry is projected to reach USD 198.0 million by 2033.
  • Multi-therapy infusion pump demand in the United Kingdom is expected to rise at 9% CAGR through 2033.
  • The multi-therapy infusion pumps market in China is expected to reach a valuation of USD 16.2 million by 2033, securing a 3% CAGR.
  • Japan market is forecast to witness a CAGR of 1% from 2023 to 2033.

“Increasing need for accurate and reliable drug/treatment delivery solutions is expected to fuel multi-therapy infusion pump demand. To maximize profits, key manufacturers are advised to develop pumps with multi-faceted features targeted at strategic user segments.” – says a lead analyst at Future Market Insights (FMI) analyst 

Who is winning?

The global multi-therapy infusion pumps market is highly competitive with a significant number of players vying for market share. Few of the leading multi-therapy infusion pump manufacturers profiled in the report include MOOG Inc., pfm medical ag, BD, AVA Biomedical, ICU Medical, ANGEL Electronics, and B. Braun among other companies.

Key players are investing in research and development endeavors to create novel and inventive solutions that provide improved effectiveness, accuracy, and affordability. They are also concentrating on broadening their range of products and reinforcing their distribution channels to meet the changing demands of clients.

Tactical alliances and associations with other corporations are progressively prevalent in the sector, enabling participants to utilize one another’s capabilities and broaden their influence in the marketplace.

Consolidation and mergers are being utilized by leading players to fortify their market standing and acquire entry to fresh markets. The sector is experiencing notable expansion in developing economies, especially in nations such as India and China.

Key players are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks. They are also focusing on offering cost-effective solutions to customers in these markets to gain a competitive edge.

Recent Developments:

  • In 2023, to boost its healthcare expertise, PFM announced the asset acquisition of Melio & Company.
  • In 2022, Capillary Biomedical, a leading infusion set developer was acquired by Tandem Diabetes Care.

Enhance Your Business Strategy Instantly Access the Full Report

Multi-Therapy Infusion Pumps Market Segmentation:

By Modality:

  • Pole Mounted
  • Table Top

By Application:

  • Parenteral Nutrition
  • Analgesic Therapy
  • Chemotherapy
  • Antibiotic Therapy
  • Desferal Therapy
  • Chronotherapy

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Clinics
  • Homecare Setting

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cervical Cancer Screening Market to Surge to USD 5.7 Billion by 2033, Reports Future Market Insights

According to the latest analysis by Future Market Insights, the global cervical cancer screening market is poised for remarkable growth, with projections indicating a leap from USD 1.6 billion in 2023 to an impressive USD 5.7 billion by 2033. This anticipated growth reflects a robust compound annual growth rate (CAGR) of 13.7%, driven by the increasing incidence of cervical cancer and significant advancements in screening technologies.

Cervical cancer, now recognized as a major healthcare challenge globally, is seeing a concerning rise in both new and existing cases. A report published by the American Society of Clinical Oncology in 2020 highlighted a dramatic 20% increase in cervical cancer patients compared to pre-pandemic levels. This spike in cases outpaces the growth rates of other common cancers, underscoring the critical need for effective screening and early detection strategies.

Grab Your Exclusive Sample Report: Unveiling the Spectacular Growth of the Cervical Cancer Screening Market

The exponential growth trajectory of the cervical cancer screening market underscores the critical role of innovative technologies and proactive healthcare initiatives in combating this pervasive disease. Through timely intervention facilitated by effective screening methodologies, the impact of cervical cancer can be substantially mitigated, leading to improved patient outcomes and enhanced public health outcomes globally.

Key stakeholders in the healthcare ecosystem, including medical professionals, researchers, policymakers, and industry leaders, are urged to collaborate synergistically to leverage these transformative advancements in cervical cancer screening. By fostering a comprehensive approach encompassing early detection, diagnosis, and treatment, we can collectively strive towards a future where cervical cancer no longer poses a formidable threat to public health.

Key Takeaways:

  • Human papillomavirus (HPV) is the leading segment of tests among end users and held about 75.0% market share in 2022, for risk stratification, HPV testing offers useful information. HPV comes in a variety of forms, including high- and low-risk varieties. While low-risk HPV variants typically result in benign genital warts, high-risk HPV strains are linked to an elevated risk of cervical cancer.
  • By cancer, squamous cell carcinomas are the predominant type and are significantly linked to high-risk HPV infections, particularly those caused by HPV types 16 and 18.
  • 31 to 65 years held the maximum market share of 61.7%, the age range of 31 to 65 years includes a time when people’s rate of cumulative exposure to HPV has become high.
  • Hospital segment by end user accounted for a revenue share of 39.7% in the global market at the end of 2022. Hospitals often have advanced diagnostic facilities and equipment, including imaging technologies, pathology laboratories, and access to specialized tests. These resources can support a comprehensive diagnostic workup and aid in reaching an accurate diagnosis.
  • By region, North America is leading in the global Cervical Cancer Screening market and is expected to continue to do so with a projected CAGR rate of 12.6% during the forecasted years.

“Increasing adoption of screening for the identification of cervical cancer, advancements in detection and management for improved outcomes are the key drivers of the Cervical Cancer Screening market,” says an analyst at Future Market Insights (FMI).

Market Competition:

In their pursuit of market expansion, key players in the Cervical Cancer Screening industry are employing growth strategies such as acquisitions, mergers, collaborations, and partnerships. These companies prioritize enhancing sales efforts and leveraging new technologies to develop innovative products.

  • According to the new In-Vitro Diagnostic Medical Devices Regulation (IVDR) in Germany, which replaces the old IVDD requirements, QIAGEN announced in October 2022 that their top in-vitro diagnostic (IVD) kit and its fully automated NeuMoDx platforms have been certified.
  • Everlywell a company that operates in Austin considerably broadened its horizons in March 2021 with the aid of double acquisitions and a restructuring that involved the creation of a parent company, all directed by Everlywell CEO and co-founder Julia Cheek.

Step Up Your Strategy Access the Detailed Report Now

Key Players:

  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche
  • Hologic, Inc.
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Sysmex Inostics Inc.
  • Danaher (Cepheid)
  • FUJIREBIO
  • Everlywell, Inc.
  • Sansure Biotech Inc.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Cervical Cancer Screening market in its latest study, presenting a historical demand assessment of 2012 to 2022 and projections for 2023 to 2033. The global Cervical Cancer Screening market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Key Segments Covered:

By Test:

  • Cervical Cytology (Pap smear)
  • Human Papillomavirus (HPV)
  • Visual inspection with acetic acid (VIA)

By Cancer:

  • Squamous Cell Carcinomas
  • Adenocarcinomas

By Age Group:

  • 21 to 30 Years
  • 31 to 65 Years

By End User:

  • Hospitals
  • Cancer Research Institutes
  • Specialty Clinics
  • Diagnostic Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Breast Fillers Market Set for Significant Growth USD 759.6 Million by 2033

Future Market Insights has released its latest industry analysis, projecting robust growth for the global breast fillers market over the next decade. According to the report, the market, currently valued at USD 415.1 million in 2023, is anticipated to expand at a compound annual growth rate (CAGR) of 6.2%. By 2033, the market is expected to reach approximately USD 759.6 million.

Breast fillers, while not traditionally marketed for breast augmentation, are gaining traction as a popular off-label option for enhancing breast volume and addressing various skin conditions such as sagging and wrinkles. These injectable dermal fillers, primarily composed of hyaluronic acid (HA)—a naturally occurring substance known for its ability to maintain skin hydration and firmness—offer a minimally invasive alternative to conventional breast augmentation surgeries.

Get your Sample Report Breast Fillers Market…

The growth in the breast fillers market is partly driven by the diversification of product offerings in the field of breast reconstruction surgery and treatments. As demand increases, so does the variety of available products, which now include more shapes, sizes, and materials, allowing for personalized treatment plans that cater to the unique needs and preferences of each patient.

“An expanded product line not only provides multiple options for women undergoing breast reconstruction but also propels market growth by meeting diverse consumer demands,” explains a leading analyst at Future Market Insights. “Breast fillers offer significant advantages by facilitating a customized approach that aligns with the patient’s desired outcomes and body shape.”

In comparison to more invasive procedures such as fat transfers or surgical implants, breast fillers represent a non-surgical option that involves fewer risks, less recovery time, and no significant scarring. This makes dermal fillers an attractive choice for women looking to enhance their breast size or shape without extensive surgery, benefiting from a procedure that allows them to continue their daily activities with minimal interruption.

The ongoing advancements in breast filler technologies and the broadening of their applications are expected to continue driving market growth, with manufacturers benefiting from the rising demand for innovative and effective non-surgical cosmetic solutions.

Key Takeaways from Market Study:

  • Hyaluronic acid is the leading segment as a product among women and professionals, and held about 76.2% market share in 2022, due to many patients prefer this as it allows them to adjust the size and shape of their breasts over time and avoid any long-term complications. Hyaluronic acid fillers can last up to 18 months, depending on the specific product used and the individual patient’s metabolism.
  • By end user, the hospitals dominated the global Breast Fillers market holding a total market share of about 42.2% by the end of 2022. After a Breast Fillers injection, patients require follow-up care to ensure that the injection site has healed properly and that the desired results have been achieved. Hospitals have the resources and infrastructure to provide this level of care, which is essential for ensuring patient satisfaction and safety.
  • By region, North America is leading in the global Breast Fillers market and is expected to continue to do so with a projected CAGR rate of 7.3% during the forecasted years.

Market Competition:

Key participants in the market for Breast Fillers are concentrating on strategies like launch of new products in their existing portfolio and acquisition of competitor firm.

  • In March 2021, Sinclair Pharma announced the launch of their Perfectha® Deep range of dermal fillers in the UK. These fillers are designed to provide volume and contouring to the face, and can also be used for body contouring, including breast augmentation.
  • In June 2021, AbbVie Inc. completed its acquisition of Allergan plc, which includes Allergan’s medical aesthetics portfolio, including Botox and Juvéderm dermal fillers.

Discover Key Insights Request Full Report Access Now

Key Players:

  • Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
  • Top Dermal
  • AbbVie Inc. (Allergan PLC)
  • Merz Pharma GmbH & Co. KGaA.
  • Croma Pharma GmbH.
  • Galderma SA
  • Cytophil Inc.
  • Macromed, Huons Global Co. Ltd. (Humedix)
  • Prollenium Medical Technologies
  • BioScience GmbH
  • Hologic, Inc
  • Bioxis pharmaceuticals

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Breast Fillers market in its latest study, presenting a historical demand assessment of 2016 to 2022 and projections for 2023 to 2033. The global Breast Fillers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Key Segments Covered in Breast Fillers Industry Research:

By Product:

  • Hyaluronic acid
  • Polylactic acid
  • Platelet-rich plasma (PRP) injections

By End User:

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgical Centers
  • Medical Spas

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Celiac Disease Diagnostics Market Set for Remarkable Growth, Projected to Reach USD 647.3 Million by 2033

The global celiac disease diagnostics market is on a significant upward trajectory, with projections indicating it will reach an impressive value of USD 647.3 million by the year 2033. This forecast represents a robust Compound Annual Growth Rate (CAGR) of 8.3%, a substantial increase from its current valuation of approximately USD 292.8 million in 2023.

Celiac disease, an autoimmune disorder triggered by the ingestion of gluten, affects millions worldwide. As awareness of this condition grows, so does the demand for advanced diagnostic solutions. These solutions are critical in identifying and managing the disease, particularly as its prevalence increases globally.

Explore the Booming Celiac Disease Diagnostics Market with Our Sample Report

Individuals with celiac disease experience adverse reactions to gluten, a protein found in wheat, rye, and barley. When gluten is consumed, the body’s immune system mistakenly attacks the small intestine lining, leading to various symptoms including bloating, diarrhea, weight loss, and abdominal pain. Left untreated, celiac disease can result in severe complications such as malnutrition and an elevated risk of developing certain cancers.

The escalating prevalence of celiac disease underscores the urgent need for improved diagnostic capabilities. The global market for celiac disease diagnostics is positioned to address this demand, offering innovative solutions to facilitate early detection and management of the condition.

Key Takeaways:

  • North America is expected to remain the largest market for celiac disease diagnostics throughout the forecast period.
  • The celiac disease serology tests segment is expected to account for the largest share of the market in 2023, but the molecular diagnostics segment is expected to grow at the fastest CAGR during the forecast period.
  • The rising demand for non-invasive and point-of-care diagnostic tests is expected to boost the growth of the celiac disease diagnostics market in the coming years.

Factors driving the growth of the celiac disease diagnostics market:

  • Increasing awareness of celiac disease: Celiac disease is a chronic autoimmune disorder that causes damage to the small intestine when gluten is consumed. Gluten is a protein found in wheat, rye, and barley. While celiac disease has been known for centuries, awareness of the disease has increased significantly in recent years. This is due in part to public awareness campaigns by celiac disease organizations as well as the increasing availability of gluten-free foods.
  • Rising prevalence of celiac disease: The prevalence of celiac disease is estimated to be around 1% of the global population. However, some studies suggest that the prevalence may be even higher. This is likely due to a number of factors, including genetic predisposition, environmental triggers, and the increased consumption of gluten-containing foods.
  • Increasing availability of diagnostic tests: There are a number of diagnostic tests available for celiac disease. The most common test is a blood test that looks for antibodies to gluten. If the blood test is positive, a biopsy of the small intestine may be performed to confirm the diagnosis. In recent years, there has been an increasing development of non-invasive diagnostic tests, such as genetic testing and stool testing. These tests are still under development, but they have the potential to make the diagnosis of celiac disease easier and more accessible.

Revolutionize Your Approach Request Full Report Access Now

Competitive Landscape:

Major market players are prioritizing the expansion of their product ranges to bolster their market standing and extend their reach into emerging markets. A primary strategy employed by manufacturers to gain a competitive advantage involves forming partnerships and acquiring other companies to broaden their business scope.

For example:

  • Thermo Fisher Scientific Inc. revealed plans in December 2021 to acquire PPD Inc., a prominent global provider of clinical research services for the biopharmaceutical and biotech sectors.
  • In November 2017, Glutenostics forged a partnership with major US Celiac Advocacy Groups.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • PRIMA Lab SA
  • Glutenostics, Inc.
  • NanoRepro AG.
  • Targeted Genomics
  • YORKTEST Laboratories
  • Biohit Oyj
  • Labsystems Diagnostics Oy
  • RxHome Test
  • Biomerica
  • AESKU.GROUP GmbH
  • LaCAR MDx Technologies
  • J. Mitra & Co. Pvt. Ltd.
  • Imaware
  • Vitrosens Biotechnology
  • Bio-Rad Laboratories Inc.
  • Eurofins Scientific

Key Segments Covered in Celiac Disease Diagnostics Industry Research:

By Product Type:

  • Serology Rapid Testing Kits
    • Transglutaminase Antibody Test Kits
    • Endomysial Antibody Test Kits
    • Anti-Giladin Antibody Test Kits
  • Genetic Rapid Testing Kits

By Technique:

  • Immunochromatography (Lateral Flow)
  • enzyme-linked immunosorbent assay (ELISA)

By Sample:

  • Blood Serum
  • Body Fluids

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
  • Home Care Setting

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Lactic Acid Esters Market Projected to Grow at a Robust CAGR of 6.9% Through 2027

 

The global lactic acid esters market is anticipated to experience significant growth, with a projected compound annual growth rate (CAGR) of 6.9% from 2017 to 2027. This robust growth is driven by increasing demand for biodegradable and eco-friendly alternatives in various industries, including pharmaceuticals, food and beverages, and personal care. The rise in consumer awareness regarding environmental sustainability and the expanding applications of lactic acid esters in enhancing product performance are key factors contributing to the market’s positive trajectory. As industries continue to seek more sustainable solutions, the lactic acid esters market is well-positioned for substantial advancements and opportunities over the forecast period.

The analytical research report published by Future Market Insights covers various aspects of the global market for lactic acid esters. The report reveals analysis on end use industries using lactic acid esters for various applications. It lays emphasis on opportunities for growth in the lactic acid esters market along with key factors pushing the growth of the global market. The various facets of the global market across important geographies are monitored.

The report covers the impact of factors that change from region to region thus changing the scenario of the lactic acid esters market in that particular region. This gives a brief idea about the market potential for lactic acid esters in various regions that the reader can use to plan future expansion. The comprehensive research study portrays a realistic picture of the global lactic acid esters market by including a weighted market segmentation along with forecast projections from 2017 till 2027, a period of 10 years.

Elevate your Business Strategy with Insights from our Industry Overview. Request a Sample to Uncover Growth Opportunities Now!

Global Lactic Acid Esters Market: Competitive Assessment

The research report on global lactic acid esters market covers analysis on various key players operating in the market. The list includes major companies such as Stepan Company, Merck KGaA, Galactic, Corbion N.V, GODAVARI BIOREFINERIES LTD., Cellulac, Henan Jindan Lactic Acid Technology Co., Ltd., Musashino Chemical Laboratory, Ltd., Zhengzhou Tianrun Lactic Acid Co., Ltd., Shenzhen Esun Industrial Co., Ltd., QINGDAO ABEL TECHNOLOGY CO.,LTD., Yancheng Huade Biological Engineering Co.,Ltd., and Vetrtec Biosolvents Inc.

Global Lactic Acid Esters Market: Forecast Analysis

According to this research report, the global lactic acid esters market is expected to reach an estimate of around US$ 410 Mn by the end of the year of forecast, 2027, from a valuation of about US$ 209 Mn in 2017. The global market for lactic acid esters is projected to grow at a value CAGR of 6.9% during the period of assessment.

Global Lactic Acid Esters Market: Segmental Snapshot

The global lactic acid esters market is segmented on the basis of product type, application and region.

  • With respect to product type, ethyl acetate is expected to show high adoption across industries in the coming years. The ethyl acetate segment is projected to be the largest with a market share in excess of 65% during the forecast period, consequently leading the global market.
  • By application, the electronics and food and beverage segments are expected to largely contribute to the revenue growth of the global market for lactic acid esters in the coming years. Of these, the electronics segment is poised to show a much higher market value.
  • By region, North America is the largest reflecting a high market attractiveness. However, the lactic acid esters market in Asia Pacific excluding Japan (APEJ) region is expected to grow at a higher rate during the forecast period.

Global Lactic Acid Esters Market: Dynamics Influencing Growth

Higher inclination towards use of green solvents in various industries, growing electronics sector across the globe, market consolidation and expansion, favourable government policies, rising food and beverage sector, availability of technologically advanced infrastructure, increasing focus on value added products coupled with favourable FDI policies, availability of natural feedstock and growth in personal care sector are expected to contribute to the growth of the global lactic acid esters market.

Contact Our Sales Team Now to Discuss How You Can Acquire This Report and Gain Valuable Insights for Your Business.

Market Segmentation

By Product Type

  • Ethyl Lactate
  • Methyl Lactate
  • Butyl Lactate
  • Others

By Application

  • Electronics
  • Paints & Inks
  • Agrochemicals
  • Pharmaceuticals
  • Food & Beverages
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pharmaceutical Sterility Testing Market Set for Explosive Growth, Projected to Reach USD 3,815.6 Million by 2033

The global pharmaceutical sterility testing market is on the brink of an extraordinary expansion, with forecasts predicting a meteoric rise from USD 1,250.7 million in 2023 to an impressive USD 3,815.6 million by 2033. This notable growth, driven by an 11.8% compound annual growth rate (CAGR), underscores the increasing demand for safe and effective medications amid a global surge in chronic diseases.

Sterility testing is a critical component in the pharmaceutical and biological industries, ensuring product safety and efficacy by identifying potential contamination risks throughout various production stages. This rigorous testing process is vital for protecting patients and maintaining high standards of healthcare.

Get Sample PDF of the Report Pharmaceutical Sterility Testing Market

This heightened demand underscores the industry’s commitment to rigorous safety standards, ensuring that all pharmaceutical products are free from viable contaminating microorganisms prior to their release into the market. The expansion of the sterility testing market is indicative of a broader trend towards higher safety standards and quality assurance in the production of medical and pharmaceutical products.

As the pharmaceutical and healthcare sectors continue to evolve, the sterility testing market is poised to play an even more pivotal role in the development and deployment of safe medical treatments, contributing to the overall growth and expansion of the global healthcare industry.

Potential Market Opportunity:

An increase in research and development expenditures in the biopharmaceutical industry contributed to the market’s expansion. For instance, in December 2021, the pharmaceutical industry’s annual research and development spending was 7.3 times higher than that of the aerospace and defense industries. Moreover, it was 6.5 times higher than that of the chemicals industry and 1.5 times higher than that of the software industry.

Key Takeaways:

  • By 2033, the pharmaceutical sterility testing market in the United Kingdom is likely to expand at a CAGR of 9.5%.
  • In 2022, the United States dominated the pharmaceutical sterility testing sector, with a share of 41.5%.
  • The pharmaceutical sterility testing market was significantly expanding, with a size of USD 1,124.7 million in 2022.
  • By 2033, the pharmaceutical sterility testing industry in China is likely to expand, with a CAGR of 12.1%.
  • By 2033, Australia is projected to expand in the pharmaceutical sterility testing business, with an expected CAGR of 10.4%.
  • The market is expected to grow to USD 1,747. 75 million valuations by 2026, with rising automated techniques.
  • By 2033, India is projected to expand significantly in the pharmaceutical sterility testing sector, with a share of 12.8%.
  • Japan’s pharmaceutical sterility testing market share expanded significantly, with a 5.1% share in 2022.
  • In 2022, the outsourced segment dominated the market with a share of 54.1%. It is anticipated to control the market by 2033 in terms of services.
  • Based on product type, kits, and reagents dominated the market with a share of 39.7% in 2022.

Power Your Business Decisions with Insights from Get Full Report Now

Key Players Operating in the Pharmaceutical Sterility Testing Market:

  • Merck KGaA
  • bioMerieux SA
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International Inc.
  • Others

Recent Developments:

  • In June 2022

For its GMP batches, Berkshire Sterile Manufacturing opened a sterility testing isolator and conducted sterility testing. It provides sterile filling of injectable medications, the bulk of which are undergoing clinical trials or have little commercial need.

STEMart has started conducting thorough sterility and microbial tests for sterile, non-pyrogenic medical equipment.

  • Thermo Fisher Scientific announced plans to build two new sterile filling lines in Singapore in October 2020. To increase capacity for producing and developing vaccines and treatments in the APAC region.

Key Segments:

By Product:

  • Kits and Reagents
  • Instruments

By Application:

  • Sterile Drugs
  • Biologics and Therapeutics
  • Medical Devices

By Test Type:

  • Sterility Testing
    • Membrane Filtration
    • Direct Inoculation
  • Bacterial Endotoxin Testing
  • Rapid Micro Test
  • Container Closure Integrity Testing
  • Electrical Resistance
  • Bioburden Testing
  • ATP Bioluminescence
  • Fluorescent Labeling
  • Others

By Services:

  • In-House
  • Outsourced

By End Use:

  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Technical Coil Coatings Market Poised for Growth: Projected to Reach USD 13.0 Billion by 2027 Driven by Rising Construction Activities

Technical Coil Coatings Market
Technical Coil Coatings Market

The technical coil coatings market is on a robust growth trajectory, expanding at a healthy CAGR of 4.9%, with its size projected to reach USD 13.0 billion by 2027. This growth is primarily fueled by increasing construction activities across both developed and developing economies, as these coatings play a critical role in enhancing the durability and aesthetic appeal of metal products used in construction. The rising demand for sustainable and energy-efficient building materials is also contributing to the market’s expansion. As urbanization continues and infrastructure development projects proliferate globally, the technical coil coatings market is poised for significant advancement, supported by technological innovations and the growing adoption of advanced coatings solutions.

Technical coil coating is a process in which a coating material is applied on the metal strip in a continuous process. The technical coil coating process involves chemical pre-treatment of the metal surface on either one side or both the sides. The process is used in many industries like construction, transportation, furniture etc.

APEJ and MEA are expected to hold a significant market potential in the global technical coil coatings market. Manufacturers are also expected to bring in to the market several latest technologies such as water based products, e-coatings and UV primers. These are radiation curable paint systems, which are expected to appeal to the masses and bring profits for businesses.

Ready to Expand Your Horizons? Request a Sample of the Technical Coil Coatings Market and Explore New Growth Opportunities Now!

Global Technical Coil Coatings Market: Drivers

An exceptional increase in the demand for corrosion free products has helped further the revenue growth of the global technical coil coatings market. The rise in demand for high-quality products to be used in the manufacturing of various consumer durable goods as well as in the electricity and power sector is being witnessed. People are also demanding more of finished goods for domestic as well as commercial use.

There is also an increase in investments in the coatings market. All these factors have highly contributed to the growth of the global technical coil coatings market. Companies are even increasing local manufacturing to strengthen their presence in the regional market. Most of the companies enter the market with support from local suppliers. These companies later strengthen their presence by strategically acquiring local partners/suppliers in the region.

Global Technical Coil Coatings Market: Segmental Analysis

  • Among the various regional markets, Asia Pacific Excluding Japan is expected to witness the fastest growth. The region is also anticipated to hold the largest market share with a valuation of over USD 700 Million by the end of 2027
  • In terms of product type, both top coats and primers are expected to turn out to be the most attractive segments with the fastest growth rate during the forecast period
  • On the basis of material type, polyester is the dominating segment in the global market, with an estimated market share of over USD 1,600 Million by the end of 2027
  • Based on application, steel is the dominant segment with a projected market value of over USD 1,700 Million by the end of 2027. The steel market is expected to grow at a CAGR of 4.8% during the forecast period
  • On the basis of end user, the body panel segment is likely to hold maximum market value share and growth rate during the forecast period

Global Technical Coil Coatings Market: Competitive Analysis

According to the research report, the top four players/manufacturers account for around 30% – 33% of the overall market share. The report comprises a brief profile of all the major players in the industry. These profiles depict the current and future strategies of all the businesses involved in this market. The research also lists the top five players in the global technical coil coatings market – Akzo Nobel N.V., Beckers Group, Axalta Coating Systems Ltd, PPG, Industries Inc. and The Valspar Corporation. Some of the other players profiled in this report include Nipsea Group, Kansai Paint Co., Henkel AG & Co. KGaA, The Chemours Company, and Axalta Coating Systems Ltd.

Contact Our Sales Team Now to Discuss How You Can Acquire This Report and Gain Valuable Insights for Your Business.

Market Segmentation:

By Material Type

  • Polyester
  • Epoxy
  • PVC/Vinyl
  • Plastisols
  • Acrylic
  • Polyurethane
  • PVDF
  • Silicone

By Product Type

  • Topcoats
  • Primers
  • Backing Coats
  • Others

By Technology

  • Liquid Coating
  • Water  Borne
  • Solvent Based
  • Powder Coating

By End Use

  • Transportation
  • Consumer Durable Goods
  • HVAC
  • Metal Furniture
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube